NEVVI Medicare utilization intelligence
+ Build a code basket
Medicare New Mexico · CY2024

Who bills the most Injection, fosaprepitant, 1 mg (J1453) to Medicare in New Mexico?

Medicare Part B FFS · CY2024 · as published by CMS
2
Billing groups
52,650
Named-group FFS services
$74,585
Named-group submitted charges
$1
Avg charge / service
$0
Avg allowed / service
Top-5 concentration
0%
Independent share

2 physician groups billed Injection, fosaprepitant, 1 mg (J1453) to Medicare fee-for-service in New Mexico in 2024; independent (non-hospital-affiliated) groups deliver 0%.

J1453 — Injection, fosaprepitant, 1 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole New Mexico market — the table below shows the top 100 groups (free tier).

Payer-mix context

Medicare fee-for-service covers 50% of Medicare in New Mexico; Medicare Advantage penetration 39% → 50% since 2020.

Market structure — concentration, independent share, and the consolidation trend for this market — is part of the market analytics platform — built, not launched yet. Notify me at launch →
#Physician groupCityStSpecialty Providers J1453 svcs Share*Phone
1 SAN JUAN ONCOLOGY ASSOCIATES PC FARMINGTONNMHEMATOLOGY/ONCOLOGY 3 39,450 63.1% (505) 564-6850
2 CANCER/BLOOD AND MEDICINE CLINIC LLC EL PASONMHEMATOLOGY/ONCOLOGY 3 13,200 21.1% (575) 650-3335

*Share of New Mexico's disclosed Medicare-FFS services for J1453, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J1453 in New Mexico — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.

How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →